Cargando…

Bimodal distribution and set point HBV DNA viral loads in chronic infection: retrospective analysis of cohorts from the UK and South Africa

Hepatitis B virus (HBV) viral load (VL) is used as a biomarker to assess risk of disease progression, and to determine eligibility for treatment. While there is a well recognised association between VL and the expression of the viral e-antigen protein, the distributions of VL at a population level a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Downs, Louise O., Vawda, Sabeehah, Bester, Phillip Armand, Lythgoe, Katrina A., Wang, Tingyan, McNaughton, Anna L., Smith, David A., Maponga, Tongai, Freeman, Oliver, Várnai, Kinga A., Davies, Jim, Woods, Kerrie, Fraser, Christophe, Barnes, Eleanor, Goedhals, Dominique, Matthews, Philippa C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2020
Materias:	Research Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682492/ https://www.ncbi.nlm.nih.gov/pubmed/33274299 http://dx.doi.org/10.12688/wellcomeopenres.15941.2

Ejemplares similares

Seroepidemiologic Survey of Crimean-Congo Hemorrhagic Fever Virus in Selected Risk Groups, South Africa
por: Vawda, Sabeehah, et al.
Publicado: (2018)

Sindbis Virus Antibody Seroprevalence in Central Plateau Populations, South Africa
por: Kennedy, Nicole, et al.
Publicado: (2022)

Barriers that prevent adults living with HBV infection from participating in clinical research: experience from South Africa
por: Mofokeng, Nombuyiselo, et al.
Publicado: (2023)

Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohort
por: Maponga, Tongai G., et al.
Publicado: (2020)

A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review
por: Mokaya, Jolynne, et al.
Publicado: (2018)

Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study
por: Wang, Tingyan, et al.
Publicado: (2021)

Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta‐analysis
por: Campbell, Cori, et al.
Publicado: (2020)

Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis
por: McNaughton, Anna L., et al.
Publicado: (2020)

Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanisms
por: Mokaya, Jolynne, et al.
Publicado: (2020)

A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action
por: Mokaya, Jolynne, et al.
Publicado: (2018)

Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults
por: Mokaya, Jolynne, et al.
Publicado: (2020)

Contamination with HIV antibody may be responsible for false positive results in specimens tested on automated platforms running HIV 4th generation assays in a region of high HIV prevalence
por: Hardie, Diana Ruth, et al.
Publicado: (2017)

Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and Pathogen
por: Lumley, Sheila F., et al.
Publicado: (2018)

Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection
por: Downs, Louise O., et al.
Publicado: (2021)

Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequences
por: McNaughton, Anna L., et al.
Publicado: (2020)

The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agenda
por: Martyn, Emily, et al.
Publicado: (2023)

The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection
por: Pley, Caitlin M, et al.
Publicado: (2021)

Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus Infection
por: Downs, Louise O., et al.
Publicado: (2019)

Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019
por: Wang, Tingyan, et al.
Publicado: (2021)

Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa
por: Mokaya, Jolynne, et al.
Publicado: (2019)

Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing?
por: Campbell, Cori, et al.
Publicado: (2023)

Insights From Deep Sequencing of the HBV Genome—Unique, Tiny, and Misunderstood
por: McNaughton, Anna L., et al.
Publicado: (2019)

Hepatitis B Virus: Infection, liver disease, carcinogen or syndemic threat? Remodelling the clinical and public health response
por: Matthews, Philippa C., et al.
Publicado: (2022)

So far, no novel SARS-CoV-2 variants from Beijing—and hopefully better scientific cooperation going forward
por: Preiser, Wolfgang, et al.
Publicado: (2023)

HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa
por: Maponga, Tongai Gibson, et al.
Publicado: (2018)

Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)
por: McNaughton, Anna L., et al.
Publicado: (2019)

Prevalence of chronic HBV infection in pregnant woman attending antenatal care in a tertiary hospital in Mwanza, Tanzania: a cross-sectional study
por: Geffert, Karin, et al.
Publicado: (2020)

Cohort Profile: The National Institute for Health Research Health Informatics Collaborative: Hepatitis B Virus (NIHR HIC HBV) research dataset
por: Wang, Tingyan, et al.
Publicado: (2022)

No point in travel bans if countries with poor surveillance are ignored
por: Preiser, Wolfgang, et al.
Publicado: (2022)

Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa
por: Jooste, Pieter, et al.
Publicado: (2016)

Persistence of Crimean-Congo Hemorrhagic Fever Virus RNA
por: Mathengtheng, Leholonolo, et al.
Publicado: (2020)

Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort
por: Adland, Emily, et al.
Publicado: (2018)

Spacer Domain in Hepatitis B Virus Polymerase: Plugging a Hole or Performing a Role?
por: Pley, Caitlin, et al.
Publicado: (2022)

Early Intervention Protocols: Proposing a Default Bimodal Bilingual Approach for Deaf Children
por: Clark, M. Diane, et al.
Publicado: (2020)

PhyloPi: An affordable, purpose built phylogenetic pipeline for the HIV drug resistance testing facility
por: Bester, Phillip Armand, et al.
Publicado: (2019)

National Institute for Health Research Health Informatics Collaborative: development of a pipeline to collate electronic clinical data for viral hepatitis research
por: Smith, David Anthony, et al.
Publicado: (2020)

HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model
por: McNaughton, Anna L., et al.
Publicado: (2019)

Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations
por: Mokaya, Jolynne, et al.
Publicado: (2021)

FAIR data needed to liberate hepatitis B virus (HBV) from the catch-22 of neglect
por: Matthews, Philippa C
Publicado: (2019)

A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policy
por: Downs, Louise O., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lhc60q10svtpln4qo66lhnibmq